A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis

摘要

There are limited data on combining delamanid and bedaquiline in drug-resistant tuberculosis (DR-TB) regimens. Prospective long-term outcome data, including in HIV-infected persons, are unavailable.